News from our innovation centres
Get up-to-date with our latest news and discover how other founders have flourished by reading our case studies.
Biotech start-up, DJS Antibodies, is the second company to move into our newly-converted class II laboratory space at the Wood Centre for Innovation.
We spoke to Peter Hamley, Chief Scientific Officer of amazing biotech start-up Samsara Therapeutics, who have just moved into the new life science labs at our Wood Centre for Innovation.
Createc has been developing smart radiation detection and 3D gamma radiation mapping technology over the last few years. Their ‘N-Visage®’ sensor has been deployed worldwide, including at the Fukushima Daichi nuclear power plant in Japan after the devastating earthquake and tsunami in 2011.
With a background from King and the Candy Crush franchise, Astrid’s new hire John Almbecker brings with him a broad experience of product development and building world-class digital consumer experiences.
CardMedic must go down as one of the fastest digital start-ups of all time: it went from concept to launch in just 72 hours and this month has signed its first agreement with Kent Surrey Sussex Air Ambulance Trust.
Based in our Oxford Centre for Innovation, Oxford Brain Diagnostics (OBD) wins £1.4m funding from the National Institute for Health Research (NIHR) to test Alzheimer’s diagnostics in the NHS.
One of our Oxford Centre for Innovation-based companies, Optellum launches the world’s first AI decision support for early lung cancer detection.
Based in our Oxford Centre for Innovation, Cold Quanta announces new milestones for its High-BIAS2 – or High Bandwidth Intertial Atom Source – project that moves the industry closer to safer skies with more precise inflight navigation systems.
We spoke to Adam Forsyth CTO of TZ, an Australian start-up at the forefront of electronic locking device development and one of our newer residents at the Oxford Centre for Innovation.
The £0.5m development – now underway – will deliver laboratory facilities to answer the significant demand that has been seen in the last year from science and tech start-ups and SMEs for lab space in Oxford’s Global Health and Life Sciences District, one of the UK’s leading technology clusters delivering lifesaving developments such as the COVID-19 vaccine.